8-KEarnings & ResultsExhibits & Filings

REGENERON PHARMACEUTICALS, INC. 8-K Report, Financial Results (Aug 4, 2016)

Filed August 4, 2016For Securities:REGN

Summary

Regeneron Pharmaceuticals, Inc. (REGN) filed an 8-K on August 4, 2016, to report its financial and operating results for the second quarter ended June 30, 2016. The press release, furnished as Exhibit 99.1, contains the detailed results for the quarter. While the 8-K itself does not provide the specific financial figures, it directs investors to the accompanying press release for comprehensive information on revenue, earnings, and operational performance. Investors should refer to the press release dated August 4, 2016, for key metrics such as revenue growth, net income, earnings per share, and updates on product sales and pipeline developments. This filing serves as an official notification of the release of these results, which are crucial for assessing the company's recent performance and future outlook.

Key Highlights

  • 1Regeneron announced its Q2 2016 financial and operating results via press release.
  • 2The press release is furnished as Exhibit 99.1 to the 8-K filing.
  • 3The filing date is August 4, 2016, with the event date also being August 3, 2016.
  • 4Investors are directed to the press release for detailed financial and operational performance data.
  • 5This 8-K primarily serves as a notification of the earnings release.
  • 6Information furnished under Item 2.02 is not considered 'filed' for certain legal purposes unless expressly incorporated by reference.

Frequently Asked Questions

The specific financial and operating results for the second quarter ended June 30, 2016, are detailed in the press release dated August 4, 2016, which is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

This 8-K filing itself does not contain the specific financial metrics. Investors should refer to the accompanying press release (Exhibit 99.1) for details on revenue, net income, earnings per share, and other relevant financial and operational data for the second quarter of 2016.

An 8-K filing is used to report material events that are of importance to shareholders or the SEC. In this case, the material event is the announcement of the company's quarterly financial results. Attaching the press release to the 8-K provides a formal and accessible way for investors to receive this information.

This specific 8-K filing focuses on reporting the Q2 2016 financial and operating results. Any updates on business developments or strategic changes would typically be found within the content of the furnished press release (Exhibit 99.1) or announced in separate 8-K filings if they constitute distinct material events.